Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial

BACKGROUND: This study sought to investigate the safety of 3‐month dual antiplatelet therapy (DAPT) in patients receiving ultrathin sirolimus‐eluting stents with biodegradable polymer (Orsiro). METHODS AND RESULTS: The SMART‐CHOICE (Smart Angioplasty Research Team: Comparison Between P2Y12 Antagonis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Kyeong Ho, Lee, Seung‐Yul, Cho, Byung Ryul, Jang, Woo Jin, Song, Young Bin, Oh, Ju‐Hyeon, Chun, Woo Jung, Park, Yong Hwan, Im, Eul‐Soon, Jeong, Jin‐Ok, Oh, Seok Kyu, Cho, Deok‐Kyu, Lee, Jong‐Young, Koh, Young‐Youp, Bae, Jang‐Whan, Choi, Jae Woong, Lee, Wang Soo, Yoon, Hyuck Jun, Lee, Seung Uk, Cho, Jang Hyun, Choi, Woong Gil, Rha, Seung‐Woon, Lee, Joo Myung, Park, Taek Kyu, Yang, Jeong Hoon, Choi, Jin‐Ho, Choi, Seung‐Hyuck, Lee, Sang Hoon, Gwon, Hyeon‐Cheol, Hahn, Joo‐Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955499/
https://www.ncbi.nlm.nih.gov/pubmed/33345567
http://dx.doi.org/10.1161/JAHA.120.018366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955499/
https://www.ncbi.nlm.nih.gov/pubmed/33345567
http://dx.doi.org/10.1161/JAHA.120.018366

Ejemplares similares